Hip fracture care during the COVID-19 pandemic: retrospective cohort and literature review.
OTA Int
; 5(1): e165, 2022 Mar.
Article
in English
| MEDLINE | ID: covidwho-1598745
ABSTRACT
OBJECTIVES:
The goal of this study was to investigate whether the COVID-19 pandemic has affected hip fracture care at a Level I Trauma hospital. The secondary goal was to summarize the published hip fracture reports during the pandemic.DESIGN:
A retrospective cohort study.SETTING:
Level I Trauma Center. PATIENTS/PARTICIPANTS:
Eighty-six operatively treated hip fracture patients age ≥65âyears, occurring from January 17 to July 2, 2020. INTERVENTION IF ANY N/A. MAIN OUTCOME MEASUREMENTS We defined 3 phases of healthcare system response pre-COVID-19 (period A), acute phase (period B), and subacute phase (periodâC). The primary outcome was 30-day mortality. Clinical outcomes including time to surgery (TTS) and length of stay (LOS) were extracted from the electronic medical record.RESULTS:
Twenty-seven patients from Period A, 27 patients from Period B, and 32 patients from Period C were included. The 30-day mortality was not statistically different. The mean TTS was 20.0â+/- 14.3 hours and was the longest in Period C (22.1â+/- 9.8âhours), but the difference was not statistically significant. The mean LOS was 113.0â+/- 66.2âhours and was longest in Period B (120.9â+/- 100.6âhours). However, the difference was not statistically significant.CONCLUSIONS:
The 30-day mortality, TTS, and LOS were not statistically different across multiple phases of pandemic at a level 1 trauma center. Our results suggest that we successfully adapted new protocol changes and continued to provide evidence-based care for hip fracture patients. Our results were comparable with that of other authors around the world.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Cohort study
/
Observational study
/
Prognostic study
/
Reviews
Language:
English
Journal:
OTA Int
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS